Similarly, GEC-specific loss of BMP and activin membrane bound inhibitor (BAMBI), a negative modulator of TGF-β signalling, resulted in podocyte loss and faster DN progression in a murine model of streptozotocin-induced diabetes84. This evidence concerns the gene TGFB1 and liver dysplastic nodule.